203 related articles for article (PubMed ID: 35991867)
1. What a Difference an Amino Acid Makes: An All-Atom Simulation Study of Nonameric Peptides in Inhibitory HLA-E/NKG2A/CD94 Immune Complexes.
Prašnikar E; Perdih A; Borišek J
Front Pharmacol; 2022; 13():925427. PubMed ID: 35991867
[TBL] [Abstract][Full Text] [Related]
2. All-Atom Simulations Reveal a Key Interaction Network in the HLA-E/NKG2A/CD94 Immune Complex Fine-Tuned by the Nonameric Peptide.
Prašnikar E; Perdih A; Borišek J
J Chem Inf Model; 2021 Jul; 61(7):3593-3603. PubMed ID: 34196180
[TBL] [Abstract][Full Text] [Related]
3. Specific recognition of HLA-E, but not classical, HLA class I molecules by soluble CD94/NKG2A and NK cells.
Brooks AG; Borrego F; Posch PE; Patamawenu A; Scorzelli CJ; Ulbrecht M; Weiss EH; Coligan JE
J Immunol; 1999 Jan; 162(1):305-13. PubMed ID: 9886400
[TBL] [Abstract][Full Text] [Related]
4. NKG2A/CD94 Is a New Immune Receptor for HLA-G and Distinguishes Amino Acid Differences in the HLA-G Heavy Chain.
Hò GT; Celik AA; Huyton T; Hiemisch W; Blasczyk R; Simper GS; Bade-Doeding C
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32575403
[TBL] [Abstract][Full Text] [Related]
5. Between Innate and Adaptive Immune Responses: NKG2A, NKG2C, and CD8⁺ T Cell Recognition of HLA-E Restricted Self-Peptides Acquired in the Absence of HLA-Ia.
Pump WC; Kraemer T; Huyton T; Hò GT; Blasczyk R; Bade-Doeding C
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30909402
[TBL] [Abstract][Full Text] [Related]
6. All-Atom Simulations Reveal the Intricacies of Signal Transduction upon Binding of the HLA-E Ligand to the Transmembrane Inhibitory CD94/NKG2A Receptor.
Ljubič M; Prašnikar E; Perdih A; Borišek J
J Chem Inf Model; 2023 Jun; 63(11):3486-3499. PubMed ID: 37207294
[TBL] [Abstract][Full Text] [Related]
7. A Conserved HIV-1-Derived Peptide Presented by HLA-E Renders Infected T-cells Highly Susceptible to Attack by NKG2A/CD94-Bearing Natural Killer Cells.
Davis ZB; Cogswell A; Scott H; Mertsching A; Boucau J; Wambua D; Le Gall S; Planelles V; Campbell KS; Barker E
PLoS Pathog; 2016 Feb; 12(2):e1005421. PubMed ID: 26828202
[TBL] [Abstract][Full Text] [Related]
8. CD94-NKG2A recognition of human leukocyte antigen (HLA)-E bound to an HLA class I leader sequence.
Petrie EJ; Clements CS; Lin J; Sullivan LC; Johnson D; Huyton T; Heroux A; Hoare HL; Beddoe T; Reid HH; Wilce MC; Brooks AG; Rossjohn J
J Exp Med; 2008 Mar; 205(3):725-35. PubMed ID: 18332182
[TBL] [Abstract][Full Text] [Related]
9. Nonameric Peptide Orchestrates Signal Transduction in the Activating HLA-E/NKG2C/CD94 Immune Complex as Revealed by All-Atom Simulations.
Prašnikar E; Perdih A; Borišek J
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34206395
[TBL] [Abstract][Full Text] [Related]
10. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.
Braud VM; Allan DS; O'Callaghan CA; Söderström K; D'Andrea A; Ogg GS; Lazetic S; Young NT; Bell JI; Phillips JH; Lanier LL; McMichael AJ
Nature; 1998 Feb; 391(6669):795-9. PubMed ID: 9486650
[TBL] [Abstract][Full Text] [Related]
11. Analysis of HLA-E peptide-binding specificity and contact residues in bound peptide required for recognition by CD94/NKG2.
Miller JD; Weber DA; Ibegbu C; Pohl J; Altman JD; Jensen PE
J Immunol; 2003 Aug; 171(3):1369-75. PubMed ID: 12874227
[TBL] [Abstract][Full Text] [Related]
12. HLA-E and HLA-E-bound peptides: recognition by subsets of NK and T cells.
Pietra G; Romagnani C; Moretta L; Mingari MC
Curr Pharm Des; 2009; 15(28):3336-44. PubMed ID: 19860683
[TBL] [Abstract][Full Text] [Related]
13. A signal peptide derived from hsp60 binds HLA-E and interferes with CD94/NKG2A recognition.
Michaëlsson J; Teixeira de Matos C; Achour A; Lanier LL; Kärre K; Söderström K
J Exp Med; 2002 Dec; 196(11):1403-14. PubMed ID: 12461076
[TBL] [Abstract][Full Text] [Related]
14. NKG2A-checkpoint inhibition and its blockade critically depends on peptides presented by its ligand HLA-E.
Battin C; Kaufmann G; Leitner J; Tobias J; Wiedermann U; Rölle A; Meyer M; Momburg F; Steinberger P
Immunology; 2022 Aug; 166(4):507-521. PubMed ID: 35596615
[TBL] [Abstract][Full Text] [Related]
15. Structural basis for NKG2A/CD94 recognition of HLA-E.
Kaiser BK; Pizarro JC; Kerns J; Strong RK
Proc Natl Acad Sci U S A; 2008 May; 105(18):6696-701. PubMed ID: 18448674
[TBL] [Abstract][Full Text] [Related]
16. Effects of Peptide on NK cell-mediated MHC I recognition.
Cassidy SA; Cheent KS; Khakoo SI
Front Immunol; 2014; 5():133. PubMed ID: 24744756
[TBL] [Abstract][Full Text] [Related]
17. Increased frequency of human leukocyte antigen-E inhibitory receptor CD94/NKG2A-expressing peritoneal natural killer cells in patients with endometriosis.
Galandrini R; Porpora MG; Stoppacciaro A; Micucci F; Capuano C; Tassi I; Di Felice A; Benedetti-Panici P; Santoni A
Fertil Steril; 2008 May; 89(5 Suppl):1490-6. PubMed ID: 17706207
[TBL] [Abstract][Full Text] [Related]
18. The inhibitory NK cell receptor CD94/NKG2A and the activating receptor CD94/NKG2C bind the top of HLA-E through mostly shared but partly distinct sets of HLA-E residues.
Wada H; Matsumoto N; Maenaka K; Suzuki K; Yamamoto K
Eur J Immunol; 2004 Jan; 34(1):81-90. PubMed ID: 14971033
[TBL] [Abstract][Full Text] [Related]
19. The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors.
Della Chiesa M; Vitale M; Carlomagno S; Ferlazzo G; Moretta L; Moretta A
Eur J Immunol; 2003 Jun; 33(6):1657-66. PubMed ID: 12778484
[TBL] [Abstract][Full Text] [Related]
20. HLA-E-bound peptides influence recognition by inhibitory and triggering CD94/NKG2 receptors: preferential response to an HLA-G-derived nonamer.
Llano M; Lee N; Navarro F; García P; Albar JP; Geraghty DE; López-Botet M
Eur J Immunol; 1998 Sep; 28(9):2854-63. PubMed ID: 9754572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
